Ambulatory blood pressure measurements are a stronger predictor of all-cause and cardiovascular mortality than clinical blood pressure measurements, according to a study published April 19 in the New England Journal of Medicine.

Although they didn’t garner as much attention as the adult guidelines, the criteria for determining hypertension in children also changed in 2017. They led to an increase in individuals considered outside the normal range, according to a study published online April 23 in JAMA Pediatrics.

New research from Michigan Technological University suggests an hour of mindfulness meditation can reduce anxiety and positively impact cardiovascular health—in particular, blood pressure. Study findings were presented April 23 at the 2018 Experimental Biology Meeting in San Diego.

Metabolically healthy obesity (MHO) is not a stable state—rather, it's a slippery slope toward metabolic syndrome and increased risk of cardiovascular disease (CVD), suggests a long-term study published April 23 in the Journal of the American College of Cardiology.

Children whose families have increased psychosocial risks are three times more likely to discontinue weight management treatment and are also less likely to improve their weight status, according to new research published April 5 in the Journal of Pediatrics.

Though research shows that fathers impact their children’s eating habits and physical activity, a study published April 10 in Preventive Medicine suggests fathers are rarely included in family interventions that combat childhood obesity.

A class of blood pressure medications—short-acting calcium channel blockers (CCBs)—was associated with an increased risk of pancreatic cancer in postmenopausal women, according to a study presented April 17 at the American Association for Cancer Research (AACR) Annual Meeting in Chicago.

A team of researchers from Geisinger Health System in Pennsylvania are attempting to curb diabetes among their patient population with a program that treats healthy food like a prescription drug—and it has delivered strong early results.